Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.

<h4>Objective</h4>To assess the effect of pharmacist interventions on glycemic control in type 2 diabetic patients and to examine factors that could explain the variation across studies.<h4>Methods</h4>A comprehensive literature search was performed in PubMed, Scopus, and LIL...

Full description

Saved in:
Bibliographic Details
Main Authors: Patricia Melo Aguiar, Giselle de Carvalho Brito, Tácio de Mendonça Lima, Ana Patrícia Alves Lima Santos, Divaldo Pereira Lyra, Sílvia Storpirtis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0150999
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849431712939900928
author Patricia Melo Aguiar
Giselle de Carvalho Brito
Tácio de Mendonça Lima
Ana Patrícia Alves Lima Santos
Divaldo Pereira Lyra
Sílvia Storpirtis
author_facet Patricia Melo Aguiar
Giselle de Carvalho Brito
Tácio de Mendonça Lima
Ana Patrícia Alves Lima Santos
Divaldo Pereira Lyra
Sílvia Storpirtis
author_sort Patricia Melo Aguiar
collection DOAJ
description <h4>Objective</h4>To assess the effect of pharmacist interventions on glycemic control in type 2 diabetic patients and to examine factors that could explain the variation across studies.<h4>Methods</h4>A comprehensive literature search was performed in PubMed, Scopus, and LILACS databases for randomized controlled trials (RCTs) published up to July 2015. The search strategy included the use of MeSH terms or text words related to pharmacist interventions, type 2 diabetes, and randomized controlled trials. RCTs published in English, Portuguese, or Spanish that evaluated the effect of pharmacist intervention on glycemic control in type 2 diabetic outpatients were included. Two independent authors executed study selection, data extraction, and risk of bias assessment. Mean differences in glycosylated hemoglobin (HbA1c) were estimated using random-effect models, and heterogeneity was evaluated by subgroup and meta-regression analyses.<h4>Results</h4>The literature search yielded 963 records of potential interest, of which 30 were included in the systematic review and 22 in the meta-analysis. Most of these RCTs were conducted in the United States in patients in outpatient clinics using face-to-face contact only. All RCTs performed patient education, and most executed the medication review. The appraised sample showed uncertain or high risk of bias in most of the items evaluated, resulting in low-quality studies. In comparison with usual care, pharmacist interventions were associated with significant reductions in HbA1c levels (-8.5% [95% CI: -1.06, -0.65]; P < 0.0001; I2 = 67.3%). Subgroup analysis indicated differences of heterogeneity by country, baseline HbA1c levels, setting, intervention frequency, and random allocation. Age and HbA1c levels partly explained the variability across studies by meta-regression.<h4>Conclusions</h4>Our findings confirmed that pharmacist interventions improve glycemic control in patients with type 2 diabetes compared with usual care and suggest that younger patients or with higher baseline HbA1c levels may be the main beneficiaries of pharmacist care.<h4>Protocol prospero registration number</h4>CRD42014007457.
format Article
id doaj-art-a306aa63bd7e4a9d9e7a08d5974aafd4
institution Kabale University
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-a306aa63bd7e4a9d9e7a08d5974aafd42025-08-20T03:27:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e015099910.1371/journal.pone.0150999Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.Patricia Melo AguiarGiselle de Carvalho BritoTácio de Mendonça LimaAna Patrícia Alves Lima SantosDivaldo Pereira LyraSílvia Storpirtis<h4>Objective</h4>To assess the effect of pharmacist interventions on glycemic control in type 2 diabetic patients and to examine factors that could explain the variation across studies.<h4>Methods</h4>A comprehensive literature search was performed in PubMed, Scopus, and LILACS databases for randomized controlled trials (RCTs) published up to July 2015. The search strategy included the use of MeSH terms or text words related to pharmacist interventions, type 2 diabetes, and randomized controlled trials. RCTs published in English, Portuguese, or Spanish that evaluated the effect of pharmacist intervention on glycemic control in type 2 diabetic outpatients were included. Two independent authors executed study selection, data extraction, and risk of bias assessment. Mean differences in glycosylated hemoglobin (HbA1c) were estimated using random-effect models, and heterogeneity was evaluated by subgroup and meta-regression analyses.<h4>Results</h4>The literature search yielded 963 records of potential interest, of which 30 were included in the systematic review and 22 in the meta-analysis. Most of these RCTs were conducted in the United States in patients in outpatient clinics using face-to-face contact only. All RCTs performed patient education, and most executed the medication review. The appraised sample showed uncertain or high risk of bias in most of the items evaluated, resulting in low-quality studies. In comparison with usual care, pharmacist interventions were associated with significant reductions in HbA1c levels (-8.5% [95% CI: -1.06, -0.65]; P < 0.0001; I2 = 67.3%). Subgroup analysis indicated differences of heterogeneity by country, baseline HbA1c levels, setting, intervention frequency, and random allocation. Age and HbA1c levels partly explained the variability across studies by meta-regression.<h4>Conclusions</h4>Our findings confirmed that pharmacist interventions improve glycemic control in patients with type 2 diabetes compared with usual care and suggest that younger patients or with higher baseline HbA1c levels may be the main beneficiaries of pharmacist care.<h4>Protocol prospero registration number</h4>CRD42014007457.https://doi.org/10.1371/journal.pone.0150999
spellingShingle Patricia Melo Aguiar
Giselle de Carvalho Brito
Tácio de Mendonça Lima
Ana Patrícia Alves Lima Santos
Divaldo Pereira Lyra
Sílvia Storpirtis
Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
PLoS ONE
title Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
title_full Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
title_fullStr Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
title_full_unstemmed Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
title_short Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
title_sort investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 diabetic patients a systematic review and meta analysis
url https://doi.org/10.1371/journal.pone.0150999
work_keys_str_mv AT patriciameloaguiar investigatingsourcesofheterogeneityinrandomizedcontrolledtrialsoftheeffectsofpharmacistinterventionsonglycemiccontrolintype2diabeticpatientsasystematicreviewandmetaanalysis
AT giselledecarvalhobrito investigatingsourcesofheterogeneityinrandomizedcontrolledtrialsoftheeffectsofpharmacistinterventionsonglycemiccontrolintype2diabeticpatientsasystematicreviewandmetaanalysis
AT taciodemendoncalima investigatingsourcesofheterogeneityinrandomizedcontrolledtrialsoftheeffectsofpharmacistinterventionsonglycemiccontrolintype2diabeticpatientsasystematicreviewandmetaanalysis
AT anapatriciaalveslimasantos investigatingsourcesofheterogeneityinrandomizedcontrolledtrialsoftheeffectsofpharmacistinterventionsonglycemiccontrolintype2diabeticpatientsasystematicreviewandmetaanalysis
AT divaldopereiralyra investigatingsourcesofheterogeneityinrandomizedcontrolledtrialsoftheeffectsofpharmacistinterventionsonglycemiccontrolintype2diabeticpatientsasystematicreviewandmetaanalysis
AT silviastorpirtis investigatingsourcesofheterogeneityinrandomizedcontrolledtrialsoftheeffectsofpharmacistinterventionsonglycemiccontrolintype2diabeticpatientsasystematicreviewandmetaanalysis